About Below The Knee Stenosis
Atherosclerosis is an artery condition affected by an accumulation of plaque in the blood that is made up of fat, cholesterol, calcium, and other substances; the plaque narrows the artery over time. Patients can experience artery narrowing in the thigh or below the knee. Most serious type of peripheral artery disease is critical limb ischemia (CLI). The occurrence of chronic ischemic rest pain, ulceration, or gangrene caused by occlusion of peripheral arterial vessels determines it. While revascularization is the first-line therapy, traditional therapies are ineffective in a number of difficult situations. The use of unconventional approaches to treat complex below-the-knee arterial disease is discussed. In addition, the state-of-the-art of gene and cell therapy for the care of patients with no other options is discussed.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Below The Knee Stenosis market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Boston Scientific Corporation (United States), Koninklijke Philips N.V. (Netherlands), Medtronic plc (United States), Shockwave Medical, Inc. (United States), Becton, Dickinson and Company (United States), OrbusNeich Medical (Hong Kong), Orchestra BioMed, Inc. (United States), Rex Medical, L.P. (United States), Bbraun (United Kingdom) and Rontis Corporation AG (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Meditek Systems (India), Hexacath (France), Vissco Rehabilitation Aids Pvt. Ltd. (India) and Essex Cardiology Group (United States).
Segmentation Overview
AMA Research has segmented the market of Global Below The Knee Stenosis market by Type (Balloon Dilation Catheter, Dual Wire Systems and Drug Eluting Stent), Application (Hospital and Ambulatory Surgical Center) and Region.
On the basis of geography, the market of Below The Knee Stenosis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Pediatric will boost the Below The Knee Stenosis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On 27th August, 2020 - Philips Completed its acquisition of Intact Vascular (Leading Invasive Peripheral Vascular Product Manufacturer), this Acquisition is Aimed to Expand Philips’ Image-Guided Therapy Devices Portfolio Across Below the Knee Stenosis.
On 22nd April, 2018 – Shockwave Launched its Intravascular Lithotripsy BTK Catheter in European Region which was Recently Received CE Mark Approval. This New Offering Is A Low-Profile Catheter Specifically Designed to Access Calcified Lesions in Below-The-Knee (BTK) Arteries Frequently Associated with Critical Limb Ischemia (CLI).
United States, Food and Drug Admiration “Paclitaxel-Coated Drug Coated Balloon and Drug-Eluting Stent Late Mortality Panel” - Provides Information Regarding the Disease Condition and Currently Marketed Devices Used for Treatment of Below the Knee Stenosis. Any New Device or Manufacturer is Required to have a FDA Approval.
Market Drivers
- Prevalence of Vascular Disorders
- Rising Healthcare Awareness
- Growth in Healthcare and Pharma Infrastructure
Opportunities
- Low Penetration in Emerging Regions Particularly Asia
Restraints
- Lack of Trained Professionals
Challenges
- Regional Regulatory Approval
- Fierce Competitive Pressure
Key Target Audience
Below the Knee Stenosis Products Manufactures, New Entrants and Investors, Below the Knee Stenosis Products Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.